Source link : https://newshealth.biz/health-news/dual-therapy-combination-shows-no-added-benefit-in-ssc-ild/
Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate alone, in a trial of systemic sclerosis-related interstitial lung disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/dual-therapy-combination-shows-no-added-benefit-systemic-2025a1000zsz?src=rss Author : Publish date : 2025-12-19 10:50:00 Copyright for syndicated content belongs to the linked Source.
The post Dual Therapy Combination Shows No Added Benefit in SSc-ILD first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-19 10:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8